Search for Clinical Trial Results
Hemorrhagic Fever - 110 Studies Found
Status | Study |
Completed |
Study Name: Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS Condition: Infection Date: 2015-02-03 Interventions: Drug: Hantavax injection Intramuscular or hypodermic injection of 0.5ml per time twice at interval of 1 |
Active, not recruiting |
Study Name: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans Condition: Crimean-Congo Hemorrhagic Fever Date: 2017-01-11 Interventions:
|
Enrolling by invitation |
Study Name: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities Condition:
Date: 2009-10-08 Interventions: Drug: Ribavirin (Virazole) Injection The drug is to be adm |
Enrolling by invitation |
Study Name: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever Condition: Viral Hemorrhagic Fever Date: 2015-06-24 Interventions: Drug: Ribavirin |
Completed |
Study Name: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) Condition: Hemorrhagic Fever, Ebola Date: 2014-10-31 Interventions: Biological: rVSVΔ-ZEBOV-GP single dose of rVSVΔ-ZEBOV-GP (3x10^6 pfu, 2x10^7 pfu or 3x10^5) |
Completed |
Study Name: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) Condition: Hemorrhagic Fever, Ebola Date: 2015-02-19 Interventions: Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso |
Active, not recruiting |
Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda Condition: Hemorrhagic Fever, Ebola Date: 2015-01-29 Interventions:
|
Recruiting |
Study Name: Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo Condition: Hemorrhagic Fever, Ebola Date: 2016-01-08 Interventions:
|
Recruiting |
Study Name: Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo Condition: Hemorrhagic Fever, Ebola Date: 2015-11-04 Interventions:
|
Completed |
Study Name: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea Condition: Hemorrhagic Fever, Ebola Date: 2015-01-12 Interventions: Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |